13 Results for "

MEK inhibitor-1

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "MEK inhibitor-1" in MCE Product Catalog:

491
491 Publications Verification
Cat. No.: HY-12031A
CAS No.: 109511-58-2
Purity:  98.57%
Research Areas:  

Cancer

U0126 is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor .
loading...
    loading...
491
491 Publications Verification
Cat. No.: HY-12031
CAS No.: 1173097-76-1
Purity:  98.92%
Research Areas:  

Cancer

U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-15610
CAS No.: 1168091-68-6
Purity:  98.74%
Synonyms: RG 7421; MEK inhibitor 1
Target:  

MEK Apoptosis

Research Areas:  

Cancer

GDC-0623 (RG 7421) is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki=0.13 nM, +ATP), and displays 6-fold weaker potency against HCT116 (KRAS (G13D), EC50=42 nM) versus A375 (BRAF V600E, EC50=7 nM).
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12042
CAS No.: 1236699-92-5
Purity:  99.88%
Synonyms: AS703026; MSC1936369B
Target:  

MEK

Research Areas:  

Cancer

Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10254G
CAS No.: 391210-10-9
Synonyms: PD0325901 (GMP); PD325901 (GMP)
Mirdametinib (PD0325901) (GMP) is Mirdametinib (HY-10254) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Mirdametinib is an orally active, selective and non-ATP-competitive MEK inhibitor .
loading...
    loading...
Cat. No.: HY-147245
CAS No.: 1858179-75-5
Purity:  98.49%
Synonyms: STP1002
Target:  

PARP

Research Areas:  

Cancer

Basroparib (STP1002) is a selective, orally active inhibitor of tankyrase (TNKS1/TNKS2) with IC50 of 29.94 nM and 3.68 nM for TNKS1 and TNKS2, respectively. Basroparib has an IC50 of >10 μM for PARP1. Basroparib binds to TNKS, stabilizes AXIN1/2 proteins, blocks Wnt/β-catenin signaling pathway, inhibits tumor cell proliferation and induces apoptosis, while reducing cancer stem cell properties. Basroparib can be used in colorectal cancer (CRC) studies with KRAS mutations (such as G12V/G12D) to overcome acquired resistance to MEK inhibitors. STP1002 has synergistic antitumor activity with MEK inhibitors .
loading...
    loading...
Cat. No.: HY-139638
CAS No.: 2570386-36-4
Purity:  98.89%
Target:  

MEK

Research Areas:  

Cancer

MEK4 inhibitor-1 is a novel MEK4 inhibitor against pancreatic adenocarcinoma with an IC50 value of 61 nM.
loading...
    loading...
Cat. No.: HY-146127
CAS No.: 3069455-54-2
Target:  

MEK

Research Areas:  

Cancer

Grb2 SH2 domain inhibitor 1 is an inhibitor of the Grb2 SH2 domain with an IC50 of 0.40 μM. Grb2 SH2 domain inhibitor 1 is also a cell-permeable cyclic peptide that can enter the cytosol of mammalian cells. Grb2 SH2 domain inhibitor 1 downregulates the expression level of p-MEK. Grb2 SH2 domain inhibitor 1 can be used in the research of breast cancer .
loading...
    loading...
Cat. No.: HY-P4133
CAS No.: 355367-87-2
Target:  

ERK MEK

Research Areas:  

Others

MEK1 Derived Peptide Inhibitor 1 is a ERK2 inhibitor that inhibits the activation of ERK2 by MEK1 in vitro, with an IC50 of 30 μM, and exhibits selectivity for ERK over JNK and p38 kinases. MEK1 Derived Peptide Inhibitor 1 can be used to study ERK activation and ERK-mediated responses .
loading...
    loading...
Cat. No.: HY-P4136
Target:  

ERK

Research Areas:  

Cancer

Myristoyl-MEK1 Derived Peptide Inhibitor 1 is the myristoylated form of the MEK1 Derived Peptide Inhibitor 1 (HY-P4133). Myristoyl-MEK1 Derived Peptide Inhibitor 1 inhibits ERK activation with an IC50 of 10 μM .
loading...
    loading...
Cat. No.: HY-12042A
CAS No.: 1236361-78-6
Synonyms: AS703026 hydrochloride; MSC1936369B hydrochloride
Target:  

MEK

Research Areas:  

Cancer

Pimasertib hydrochloride is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor .
loading...
    loading...
Cat. No.: HY-107619
CAS No.: 548756-68-9
Purity:  99.72%
Target:  

MEK

Research Areas:  

Cancer

PD-334581 is a MEK1 inhibitor .
loading...
    loading...
Cat. No.: HY-107619R
CAS No.: 548756-68-9
Target:  

Reference Standards MEK

Research Areas:  

Cancer

PD-334581 (Standard) is the analytical standard of PD-334581 (HY-107619). This product is intended for research and analytical applications. PD-334581 is a MEK1 inhibitor .
loading...
    loading...
  • 1